Skip to main content
Clinical Trials/NCT04776356
NCT04776356TerminatedNot Applicable

Prospective Study to Evaluate the Continued Safety and Effectiveness of the QuickFix Small Staple to Correct Hallux Valgus Interphalangeus

Arthrex GmbH1 site in 1 country12 target enrollmentStarted: May 25, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
12
Locations
1
Primary Endpoint
Change of Foot and Ankle Ability Measure (FAAM Sport)

Study Overview

Brief Summary

The prospective, post-market, single-center clinical study will include 45 subjects who are candidates for surgery using the Arthrex QuickFix Small Staple for Akin osteotomy to correct hallux valgus interphalangeus. The purpose of the study is to evaluate the continued safety and effectiveness of the device. Device-related adverse events as well as patient reported outcomes (VAS, FFI, FAAM, VR-12) will be collected up to 1 year postoperative.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject requires surgery using the Arthrex QuickFix Small Staple for Akin osteotomy.
  • Subject is 18 years of age or older.
  • Subject is not considered a vulnerable subject (i.e. child, pregnant, nursing, prisoner, or ward of the state).
  • Subject signed informed consent and is willing and able to comply with all study requirements.

Exclusion Criteria

  • Insufficient quantity or quality of bone.
  • Blood supply limitations and previous infections which may retard healing.
  • Foreign-body sensitivity.
  • Any active infection or blood supply limitations.
  • Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
  • Subjects that are skeletally immature.

Outcomes

Primary Outcomes

Change of Foot and Ankle Ability Measure (FAAM Sport)

Time Frame: preoperatively, 3 months, 6 months and 12 months postoperative

Measuring foot functionality. Range 0-100 (0=worst, 100=best)

Change of Foot Function Index (FFI)

Time Frame: preoperatively, 3 months, 6 months and 12 months postoperative

Measuring foot functionality. Range 0-100 (0=best, 100=worst)

Change of Veterans RAND 12 Iteam Health Survey (VR-12)

Time Frame: preoperatively, 6 months and 12 months postoperative

Measuring quality of life. Range 0-100 (0=worst, 100=best)

Change of Visual Analogue Scale (VAS)

Time Frame: preoperatively, 2 weeks, 6 week, 3 months, 6 months and 12 months postoperative

Measuring pain in the affected foot. Range 0-10 (0=best, 10=worst).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Arthrex GmbH
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials